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Introduction / objectives
Enterococcus faecium has become a major cause of
nosocomial infections especially in patients with hema-
tologic malignancies. The aim of this study was to deter-
mine risk factors in those patients who are at risk of
Enterococcus faecium blood stream infection (BSI) and
should be considered for empirical treatment.
Methods
Retrospectively demographic, clinical and microbiologi-
cal data in 33 patients with an E. faecium BSI were
compared to 66 control patients during a 5-year period
at the hematology ward. Multivariate logistic regression
was used to explore the independent risk factors in
order to develop a prognostic model to determine the
risk of E. faecium BSI.
Results
Significant associations of E.faecium BSI were found
with age, hospital stay prior to blood culture, duration
of hospitalization 1 year before admission, fever prior to
blood culture, severity and duration of neutropenia,
CRP (C-reactive protein) at time of blood culture with-
drawal, colonization with E. faecium prior to blood cul-
ture and diarrhea. E. faecium BSIs were found
associated with more severe disease and higher mortality
rates. Independent risk factors for E. faecium BSI were
colonization with E. faecium 30 days prior to blood cul-
ture (OR 3.83; CI 1.1-12.8), fever > 1 day (4.02; 1.3-
12.8), hospital stay prior to blood culture > 14 days
(4.78; 1.3 -18.0), age > 59 years (5.47; 1.6-18.2) and
abdominal pain, diarrhea or neutropenia (5.95; 1.1-31.4).
Conclusion
Using prognostic modeling, risk stratification is possible
for development of E. faecium BSI in patients with
hematological malignancies. Empirical treatment should
be considered in patients who are at high risk.
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